Polycythemia Vera

PV at ASCO 2026

View All

Panel discussion on treatment options and future research in polycythemia vera featuring Dr. Anand Patel, Dr. Aaron Gerds, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Anthony Hunter.

PV at ASCO 2026

06/11/2026

Treatment Selection and Future Directions in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD

Panel of four doctors discussing molecular responses and long-term disease control in polycythemia vera, highlighting recent research and treatment strategies.

PV at ASCO 2026

06/10/2026

Molecular Responses and Long-Term Disease Control in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD

Panel of four doctors discussing treatment strategies for polycythemia vera, focusing on optimizing ropeginterferon therapy, with a city skyline background.

PV at ASCO 2026

06/09/2026

Optimizing Ropeginterferon Use in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD

Panel of four doctors discussing current treatment paradigms and the emerging role of Ropiginterferon in polycythemia vera (PV) at OncUpdates.

PV at ASCO 2026

06/08/2026

Current Treatment Paradigms and the Emerging Role of Ropeginterferon Alfa-2b-njft in PV

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD

Experts discuss the role of Ropoginterferon Alfa-2b in treating Polycythemia Vera, highlighting recent clinical insights and therapeutic strategies.

PV at ASCO 2026

05/31/2026

Clinical Insights: Role of Ropeginterferon Alfa-2b-njft in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD

PV at ASH 2025

View All

1. Expert panel discussing managing fatigue and phlebotomy burden in pulmonary embolism patients using Rusteride at OncUpdates conference.

PV at ASH 2025

01/10/2026

Ep. 4: Managing Fatigue and Phlebotomy Burden in PV With Rusfertide

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD

Managing Hematocrit and Symptoms in PV: Dose Titration Strategies for Rusfertide.

PV at ASH 2025

01/08/2026

Ep. 3: Managing Hematocrit and Symptoms in PV: Dose-Titration Strategies for Rusfertide

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD

1. A group of medical researchers and doctors discussing cancer treatment algorithms in a professional conference setting.

PV at ASH 2025

01/06/2026

Ep. 2: Integrating Rusfertide Into the Polycythemia Vera Treatment Algorithm

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD

1. Innovative hematocrit control approaches in polycythemia vera presented by leading oncology experts for improved patient management.

PV at ASH 2025

01/02/2026

Ep. 1: Clinical Insights: New Approaches to Hematocrit Control in Polycythemia Vera

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD

Polycythemia Vera management insights, hematocrit control, and clinical treatment strategies by Dr. Andrew Kuykendall, Dr. Aaron Gerds, Dr. Talha Badar, Dr. Rohit Gosain, and Dr. Rahul Gosain.

PV at ASH 2025

12/22/2025

Clinical Insights: VERIFY Trial Shows Rusfertide’s Potential to Transform PV Treatment (Full Video)

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD